Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Ashley

Showing results (161-170 of 167) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 167 results.
Sexually Transmitted Diseases|December 15, 2007
Type-specific seroprevalence of herpes simplex virus type 2 and associated risk factors in middle-aged women from 6 countries: the IARC multicentric studyPadmaja Patnaik, Rolando Herrero, R Ashley Morrow, et al.
International Journal of Radiation Oncology, Biology, Physics|December 10, 2013
Mobilization of viable tumor cells into the circulation during radiation therapyOlga A Martin, Robin L Anderson, Prudence A Russell, et al.
Brain : a Journal of Neurology|May 7, 2026
Autologous adipose-derived mesenchymal stromal cells for chronic traumatic brain injuryCharles S Cox, Janet R Ashley, Jenifer Juranek, et al.
The New England Journal of Medicine|January 2, 2004
Once-daily valacyclovir to reduce the risk of transmission of genital herpesLawrence Corey, Anna Wald, Raj Patel, et al.
JAMA|August 4, 1999
Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV Vaccine Study GroupL Corey, A G Langenberg, R Ashley, et al.
ACS Medicinal Chemistry Letters|January 21, 2017
Discovery of Chromane Propionic Acid Analogues as Selective Agonists of GPR120 with <i>in Vivo</i> Activity in RodentsGregory L Adams, Francisco Velazquez, Charles Jayne, et al.
ACS Medicinal Chemistry Letters|January 21, 2017
Design, Synthesis, and Evaluation of Novel and Selective G-protein Coupled Receptor 120 (GPR120) Spirocyclic AgonistsJason M Cox, Hong D Chu, Mariappan V Chelliah, et al.
Pageof 17

Showing results (161-170 of 167) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 167 results.
Sexually Transmitted Diseases|December 15, 2007
Type-specific seroprevalence of herpes simplex virus type 2 and associated risk factors in middle-aged women from 6 countries: the IARC multicentric studyPadmaja Patnaik, Rolando Herrero, R Ashley Morrow, et al.
International Journal of Radiation Oncology, Biology, Physics|December 10, 2013
Mobilization of viable tumor cells into the circulation during radiation therapyOlga A Martin, Robin L Anderson, Prudence A Russell, et al.
Brain : a Journal of Neurology|May 7, 2026
Autologous adipose-derived mesenchymal stromal cells for chronic traumatic brain injuryCharles S Cox, Janet R Ashley, Jenifer Juranek, et al.
The New England Journal of Medicine|January 2, 2004
Once-daily valacyclovir to reduce the risk of transmission of genital herpesLawrence Corey, Anna Wald, Raj Patel, et al.
JAMA|August 4, 1999
Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV Vaccine Study GroupL Corey, A G Langenberg, R Ashley, et al.
ACS Medicinal Chemistry Letters|January 21, 2017
Discovery of Chromane Propionic Acid Analogues as Selective Agonists of GPR120 with <i>in Vivo</i> Activity in RodentsGregory L Adams, Francisco Velazquez, Charles Jayne, et al.
ACS Medicinal Chemistry Letters|January 21, 2017
Design, Synthesis, and Evaluation of Novel and Selective G-protein Coupled Receptor 120 (GPR120) Spirocyclic AgonistsJason M Cox, Hong D Chu, Mariappan V Chelliah, et al.
Pageof 17